Liver

Metabolic-associated fatty liver disease (MAFLD)

Hours: 2 | EA: 1.5 | MO: 0 | RP: 0.5

GPs must be able to assess the severity of metabolic-associated fatty liver disease in primary care and guide their patients' future management to determine the need for referral to secondary care or management in primary care. This course will help GPs to understand the additional steps that are required to ensure that the underlying cause is determined and addressed.

Management of patients with advanced liver disease: The role of the general practitioner

Hours: 2 | EA: 1.5 | MO: 0 | RP: 0.5

Early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. This course will show GPs how to identify cirrhosis, how to prevent and manage the complications of cirrhosis, and the important role they play in the integrated care of the patient with cirrhosis.

The rising health threat of liver disease: What GPs can do to prevent premature mortality

Advanced course | Hours: 7 | EA: 5 | MO: 0 | RP: 2

Liver disease now affects up to 3 of every 10 Australian adults. Primary liver cancer is the most rapidly rising cause of cancer death. Health promotion, prevention, proactive case-finding, early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. Learn how to identify, manage and support your patients with liver disease.
RELX Group plc